Kirkland & Ellis advised private equity firm Windjammer Capital on the acquisition of Bio X Cell LLC in partnership with management. The transaction was announced December 13, 2023. Bio X Cell is a leading producer of monoclonal antibodies for use in both in vivo and in vitro pre-clinical research applications.
The Kirkland team was led by corporate partners Amanda Border and Christian Atwood; tax partner Vin Thorn; and debt finance partner Brian Ford.
LEGAL DESIRE NEWSLETTER
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.